Gen’s report, ‘Global Lutein Esters Market – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2021’ provides detailed market and segment level data on the Global and Chinese consumption of Lutein Esters. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021.
Although the main strut of research behind lutein and zeaxanthin remains their benefits for eye health, there has also been a wealth of research into lutein's positive effect on boasting the skin's hydration and elasticity. In addition, researchers from France last year reported that zeaxanthin could help improve mental performance in the elderly. And in 2006, Swedish researchers reported that people suffering from coronary artery disease have low levels of lutein and zeaxanthin. Market A report last summer from analysts Frost & Sullivan said the global lutein market is set to hit $124.5m in 2013. In 2006, they valued the market at $105.1m. According to the report, manufacturers need to address this growing maturity in dietary supplements by identifying new and potentially lucrative application segments that offer opportunities for the continued growth of the lutein market. The zeaxanthin market is estimated to be worth about $2m.
Indeed, both companies say the strengthened partnership will help aid future lutein growth. A report this summer from analysts Frost & Sullivan said the global lutein market is set to hit $124.5 million (€93 million) in 2013. Last year they valued the market at $105.1 million (€78.4 million). According to the report, manufacturers need to address this growing maturity in dietary supplements by identifying new and potentially lucrative application segments that offer opportunities for the continued growth of the lutein market. Lutein, a nutrient found in various foods including green leafy vegetables and egg yolk, has a ten-year history in the dietary supplement market as a nutrient to reduce the risk of age related macular degeneration (AMD). AMD affects the central part of the retina called the macula, which controls fine vision, leaving sufferers with only limited sight. AMD affects over 30 million people worldwide, and is the leading cause of blindness in people over 50. The main strut of research behind lutein remains its benefits for eye health, which augurs well for the future of the ingredient, says the report, since eye health ranks among the top five health concerns in the United States and various European countries.